Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CROFF ENTERPRISES INC | 2,125,000 | reported | 31 Mar 2022 | tx 4+9,750,000 |
| PUMA BIOTECHNOLOGY, INC. | 25,748 | reported | 09 Jun 2020 | tx 2+110,949 |
| Neon Therapeutics, Inc. | 0 | reported | 06 May 2020 | tx 10+558,868−1,567,430 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Mar 2022 | GRANT_AWARD | CROFF ENTERPRISES INC | 2,125,000 | 0.00 USD | deriv |
| 23 Mar 2022 | GRANT_AWARD | CROFF ENTERPRISES INC | 2,125,000 | 0.00 USD | deriv |
| 31 Aug 2021 | GRANT_AWARD | CROFF ENTERPRISES INC | 2,750,000 | 0.00 USD | deriv |
| 31 Aug 2021 | GRANT_AWARD | CROFF ENTERPRISES INC | 2,750,000 | 0.00 USD | deriv |
| 09 Jun 2020 | GRANT_AWARD | PUMA BIOTECHNOLOGY, INC. | 25,748 | 0.00 USD | |
| 06 May 2020 | OTHER | Neon Therapeutics, Inc. | 776,085 | — | |
| 06 May 2020 | OTHER | Neon Therapeutics, Inc. | 354,632 | — | deriv |
| 06 May 2020 | OTHER | Neon Therapeutics, Inc. | 200,000 | — | deriv |
| 06 May 2020 | OTHER | Neon Therapeutics, Inc. | 208,062 | — | deriv |
| 29 Feb 2020 | TAX_WITHHOLDING | Neon Therapeutics, Inc. | 9,783 | 1.50 USD | |
| 12 Jan 2020 | GRANT_AWARD | Neon Therapeutics, Inc. | 240,000 | 0.00 USD | |
| 15 Oct 2019 | GRANT_AWARD | PUMA BIOTECHNOLOGY, INC. | 85,201 | 0.00 USD | deriv |
| 27 Feb 2019 | GRANT_AWARD | Neon Therapeutics, Inc. | 100,000 | 0.00 USD | |
| 27 Feb 2019 | GRANT_AWARD | Neon Therapeutics, Inc. | 200,000 | 0.00 USD | deriv |
| 20 Aug 2018 | EXERCISE | Neon Therapeutics, Inc. | 18,868 | 2.65 USD | |
| 20 Aug 2018 | EXERCISE | Neon Therapeutics, Inc. | 18,868 | 0.00 USD | deriv |